Bank of Montreal Can Has $1.94 Million Holdings in Imperva Inc (IMPV)

Bank of Montreal Can raised its holdings in Imperva Inc (NASDAQ:IMPV) by 21.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 41,778 shares of the software maker’s stock after buying an additional 7,268 shares during the quarter. Bank of Montreal Can owned 0.12% of Imperva worth $1,940,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Russell Investments Group Ltd. increased its holdings in Imperva by 276.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,588 shares of the software maker’s stock valued at $112,000 after buying an additional 1,900 shares during the period. Royal Bank of Canada increased its holdings in Imperva by 99.4% in the 1st quarter. Royal Bank of Canada now owns 2,794 shares of the software maker’s stock valued at $122,000 after buying an additional 1,393 shares during the period. Aperio Group LLC bought a new stake in Imperva in the 2nd quarter valued at $203,000. Oppenheimer & Co. Inc. bought a new stake in Imperva in the 2nd quarter valued at $222,000. Finally, Xact Kapitalforvaltning AB bought a new stake in Imperva in the 1st quarter valued at $205,000. 99.90% of the stock is currently owned by hedge funds and other institutional investors.

IMPV has been the topic of several analyst reports. Stifel Nicolaus lowered their target price on shares of Imperva from $50.00 to $48.00 and set a “buy” rating on the stock in a report on Friday, July 27th. Evercore ISI reaffirmed a “buy” rating and issued a $56.00 target price on shares of Imperva in a report on Friday, July 27th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $62.00 target price on shares of Imperva in a report on Friday, July 27th. BidaskClub lowered shares of Imperva from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 1st. Finally, ValuEngine raised shares of Imperva from a “hold” rating to a “buy” rating in a report on Thursday, October 11th. Ten investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $56.37.

IMPV opened at $56.00 on Friday. Imperva Inc has a twelve month low of $37.17 and a twelve month high of $57.65. The stock has a market capitalization of $1.96 billion, a PE ratio of -200.00 and a beta of 1.35.

Imperva (NASDAQ:IMPV) last posted its earnings results on Wednesday, October 31st. The software maker reported $0.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.25. Imperva had a negative net margin of 8.00% and a negative return on equity of 5.62%. The business had revenue of $91.63 million for the quarter, compared to analyst estimates of $89.24 million. On average, research analysts expect that Imperva Inc will post -1.06 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.americanbankingnews.com/2018/11/10/bank-of-montreal-can-has-1-94-million-holdings-in-imperva-inc-impv.html.

About Imperva

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Read More: Trading Strategy Examples and Plans

Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply